NCT02266420View on ClinicalTrials.gov

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

July 26, 2021

Study Completion Date

October 29, 2024

Conditions
Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm
Interventions
PROCEDURE

Blood samples of 10 mL

Blood samples of 10 mL will be collected at initial visit; serum samples will then be stored at the end of the study (-80°C) and may be used for the purpose of further scientific research.

Trial Locations (11)

13273

Institut Paoli Calmettes, Marseille

14076

Centre Francois Baclesse, Caen

31059

Institut Claudius Regaud, Toulouse

31130

Clinique La Croix Du Sud, Quint-Fonsegrives

34298

Institut Regional Du Cancer Montpellier, Montpellier

43000

CH Emile ROUX, Le Puy-en-Velay

44805

Institut de Cancerologie de L'Ouest - Site Rene Gauducheau, Saint-Herblain

49933

Institut de Cancerologie de L'Ouest - Site Paul Papin, Angers

63011

Centre Jean Perrin, Clermont-Ferrand

87042

CHU de LIMOGES - HOPITAL DUPUYTREN, Limoges

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT02266420 - Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm | Biotech Hunter | Biotech Hunter